Silo Pharma Inc. operates as an early stage biopharmaceutical company. It focuses on the use of psychedelic therapeutics for patients suffering from various indications, such as depression, PTSD, Alzheimer's, and other rare neurological disorders. The company was formerly known as Uppercut Brands Inc. and changed its name to Silo Pharma Inc. in September 2020. Silo Pharma Inc. was incorporated in 2010 and is based in Teaneck, New Jersey.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.17    OTCQB
As of 01/26/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Index country:  USA
Country of incorporation:  
IPO date:  12/24/2020
Outstanding shares:  98,671,970
Average volume:  112,320
Market cap:   $17,297,196
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   6.18
PB ratio:   1.70
PS ratio:   139.11
Return on equity:   41.40%
Net income %:   3,379.77%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy